BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18051729)

  • 1. [Advances in human papillomavirus therapeutic vaccine].
    Liu B; Zhao QZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):685-90. PubMed ID: 18051729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic HPV vaccines.
    Hancock G; Hellner K; Dorrell L
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():59-72. PubMed ID: 29108943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic human papillomavirus vaccines: current clinical trials and future directions.
    Hung CF; Ma B; Monie A; Tsen SW; Wu TC
    Expert Opin Biol Ther; 2008 Apr; 8(4):421-39. PubMed ID: 18352847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials.
    Tang J; Li M; Zhao C; Shen D; Liu L; Zhang X; Wei L
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer vaccines: recent advances in HPV research.
    Eiben GL; da Silva DM; Fausch SC; Le Poole IC; Nishimura MI; Kast WM
    Viral Immunol; 2003; 16(2):111-21. PubMed ID: 12828864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV vaccines: their pathology-based discovery, benefits, and adverse effects.
    Nicol AF; de Andrade CV; Russomano FB; Rodrigues LS; Oliveira NS; Provance DW; Nuovo GJ
    Ann Diagn Pathol; 2015 Dec; 19(6):418-22. PubMed ID: 26321154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a human papillomavirus vaccine.
    Rowen D; Lacey C
    Dermatol Clin; 1998 Oct; 16(4):835-8. PubMed ID: 9891690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection.
    Asiaf A; Ahmad ST; Mohammad SO; Zargar MA
    Eur J Cancer Prev; 2014 May; 23(3):206-24. PubMed ID: 24129107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in human papillomavirus vaccines.
    Mahdavi A; Monk BJ
    Curr Oncol Rep; 2006 Nov; 8(6):465-72. PubMed ID: 17091565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counseling the patient with HPV disease.
    Diaz ML
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):391-402. PubMed ID: 23732038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.
    Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Dillner J; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Maansson R; Lu S; Vuocolo S; Hesley TM; Saah A; Barr E; Haupt RM
    Cancer Prev Res (Phila); 2009 Oct; 2(10):868-78. PubMed ID: 19789295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines against human papillomavirus.
    Lin YY; Alphs H; Hung CF; Roden RB; Wu TC
    Front Biosci; 2007 Jan; 12():246-64. PubMed ID: 17127297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin and immunoescape of uterine cervical cancer.
    Van Hede D; Langers I; Delvenne P; Jacobs N
    Presse Med; 2014 Dec; 43(12 Pt 2):e413-21. PubMed ID: 25448124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic vaccines for high-risk HPV-associated diseases.
    Chabeda A; Yanez RJR; Lamprecht R; Meyers AE; Rybicki EP; Hitzeroth II
    Papillomavirus Res; 2018 Jun; 5():46-58. PubMed ID: 29277575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
    Friedek DA; Ekiel AM; Martirosian G
    Wiad Lek; 2007; 60(1-2):34-8. PubMed ID: 17607966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of vaccination with Cervarix (trade mark) on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age.
    Harper DM
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S11-7. PubMed ID: 18649932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccination: current indications and future directions.
    Gattoc L; Nair N; Ault K
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):177-97. PubMed ID: 23732024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A144-9. PubMed ID: 23176836
    [No Abstract]   [Full Text] [Related]  

  • 20. Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer.
    Morrow MP; Yan J; Sardesai NY
    Expert Rev Vaccines; 2013 Mar; 12(3):271-83. PubMed ID: 23496667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.